Chinese robotics company Unitree has set the price for its initial public offering on the Shanghai Stock Exchange at 150.8 yuan per share, as it looks to raise 6.1 billion yuan (about $840 million). The listing is a major test of whether public investors are willing to fund humanoid robot makers that have generated plenty of buzz but have yet to see widespread real-world use.
Unitree, founded in 2016 and based in Hangzhou, first made a name for itself with relatively affordable quadruped robots—often called “robot dogs.” More recently, its humanoid models, including the G1, H1, and R1, have drawn attention for their ability to run, jump, and even dance. These demonstrations have made Unitree one of the most visible players in the fast-growing humanoid robotics space, competing with the likes of Tesla’s Optimus and Boston Dynamics.
A profitable but early-stage business
According to Reuters, Unitree would be the first humanoid robot maker to list on mainland China’s stock exchanges. Its prospectus shows 2025 revenue of nearly 1.7 billion yuan and adjusted net profit of about 600 million yuan, with overseas sales contributing significantly. That profitability sets Unitree apart from many other robotics startups, which often burn through cash while developing expensive hardware.
Still, the company’s humanoid robots are in the early stages of commercial adoption. While robot dogs have found uses in industrial inspections, security patrols, and even entertainment, humanoid robots are still largely confined to pilot projects and demonstrations. The challenge for Unitree—and for the broader industry—is to move from impressive prototypes to products that businesses and consumers will actually buy in large numbers.
The IPO proceeds are expected to fund research and development, expand production capacity, and support overseas expansion. Unitree’s ability to sell robots globally, particularly in markets like the United States and Europe, will be a key factor in its growth story.
What it means for investors
For everyday investors, the Unitree IPO is a chance to gain exposure to the humanoid robotics theme, which has become one of the most talked-about areas of technology. However, it also comes with significant risks. The sector is still young, and it is unclear how quickly humanoid robots will be adopted in warehouses, factories, and homes. Companies in this space often face high development costs, regulatory hurdles, and competition from both established players and new entrants.
Investors should also note that the IPO is priced at a level that values Unitree at around 61 billion yuan (about $8.4 billion). That valuation implies high expectations for future growth, and any disappointment in the company’s ability to scale could lead to sharp share price swings.
The broader market context matters too. Chinese equities have been volatile, with investors rotating between sectors such as tech and coal, as seen in recent trading sessions. The success of Unitree’s listing could influence sentiment toward other tech IPOs in the region.
For those watching the robotics space, the key metrics to track will be order volumes, customer adoption rates, and whether Unitree can maintain its profitability while scaling up. The company’s overseas sales are particularly important, as they diversify revenue and reduce reliance on the domestic Chinese market.
Looking ahead
The Unitree IPO is not just a corporate event; it is a barometer for investor confidence in humanoid robotics. If the listing is well-received, it could encourage other robotics companies to pursue public listings, providing more opportunities for investors to participate in this emerging sector. Conversely, a weak debut could cool enthusiasm and make it harder for similar companies to raise capital.
For now, the focus will be on how the shares trade in the days after listing. Strong demand could signal that investors are willing to look past the early-stage nature of humanoid robots and bet on their long-term potential. A tepid response, on the other hand, might suggest that the market wants to see more concrete evidence of real-world adoption before committing capital.
As with any IPO, investors should do their own research and consider their risk tolerance. Humanoid robotics is an exciting field, but it is also one where the gap between hype and reality can be wide. The Unitree listing will provide a clearer picture of how the market currently views that gap.
